NCT07356310 Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
| NCT ID | NCT07356310 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Breathing |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-02-17 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-02-17 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will determine if airway resistance to airflow and pressure, measured by Oscillometry, is associated with abnormal findings on methacholine challenge testing and whether these findings are associated with body habitus,
Eligibility Criteria
Inclusion Criteria: * Willingness to perform breathing test * Must be able to speak and understand English * Referred for Methacholine Challenge Test Exclusion Criteria: * Unable to provide consent or perform oscillometry test
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07356310 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breathing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07356310 currently recruiting?
Yes, NCT07356310 is actively recruiting participants. Contact the research team at patrick_donohue@urmc.rochester.edu for enrollment information.
Where is the NCT07356310 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07356310 clinical trial?
NCT07356310 is sponsored by University of Rochester. The trial plans to enroll 100 participants.